Affiliation: AstraZeneca R and D
- Efficacy and safety of quetiapine in children and adolescents with mania associated with bipolar I disorder: a 3-week, double-blind, placebo-controlled trialSanjeev Pathak
AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA
J Clin Psychiatry 74:e100-9. 2013..To evaluate the efficacy and safety of quetiapine monotherapy in children and adolescents with mania associated with bipolar I disorder...
- Development and content validity of a patient reported outcomes measure to assess symptoms of major depressive disorderKathryn Eilene Lasch
Adelphi Values, Boston, MA, USA
BMC Psychiatry 12:34. 2012..The aim of this study was to develop a disease-specific questionnaire to assess symptoms important and relevant to adult MDD patients...